Good Morning, Traders!…👋

U.S. stock futures are trending lower Monday as markets look to extend record highs ahead of a pivotal week. The focus shifts to Wednesday’s inflation data, the last major economic release of the year, which could heavily influence the Federal Reserve’s rate decision next week.

Traders are now pricing in an 85% chance of a quarter-point rate cut, up from 62% just a week ago, according to CME’s FedWatch tool.

Geopolitical developments are also in the spotlight. Over the weekend, Syria’s President Bashar al-Assad fled the country and resigned, according to Russia’s Foreign Ministry, adding to uncertainty in the Middle East. Oil prices rose in early trading, with Brent crude climbing 0.9% to $71.79 and West Texas Intermediate advancing 1.1% to $67.95.

On the earnings front, Macy’s is set to report results after a delay last month amid an investigation into $154 million in hidden expenses. Meanwhile, Costco Wholesale is also scheduled to release its earnings later this week.

Happening Today

✓ 09:00 AM ET – NY Fed 1-Year Consumer Inflation Expectations (Nov)

PREMARKET SNAPSHOT 📈

Market futures are mixed, with the S&P 500 and NASDAQ showing declines, while the Dow is up slightly.

SECTOR SNAPSHOT✨

Yesterday, Consumer Discretionary led the way with a 2.39% increase, while Communication Services also performed well, rising by 1.38%. Information Technology saw a modest gain of 0.14%. On the downside, Energy dropped by 1.57%, and Utilities followed with a 1.19% decline. Consumer Staples, Health Care, Industrials, and Materials all experienced losses, down by 0.44%, 0.54%, 0.25%, and 0.26%, respectively. Financials and Real Estate were also slightly lower, with Financials showing a small gain of 0.03% and Real Estate dipping by 0.04%.

PreMarket Unusual Volume Stocks

📈 Innate Pharma ADR (IPHA) experienced a notable gain of 40.82%, closing at $2.07. The trading volume surged to 6.3 million shares, far exceeding its average of 11K, indicating strong market interest and activity in the stock.

📈 MEDIROM Healthcare Technologies Inc ADR (MRM) saw its stock price climb 39.02%, finishing at $4.24. The company witnessed a trading volume of 2.3 million shares, significantly higher than its average of 52K, suggesting increased enthusiasm from investors.

📈 China SXT Pharmaceuticals Inc (SXTC) reported a 20.14% rise in its stock price, ending at $0.44. With a trading volume of 17.2 million shares compared to its average of 596K, the stock showed heightened trading activity and investor attention.

📈 Zeo Energy Corp (ZEO) emerged as a major gainer, soaring 128.15% to close at $3.08. The trading volume of 20.7 million shares was well above its average of 1.04 million, highlighting robust demand for the stock.

📈 Algorhythm Holdings Inc (RIME) recorded a 27.17% increase in its stock price, closing at $0.12. The company traded an impressive 60.5 million shares, significantly outpacing its average volume of 5.5 million, reflecting strong investor interest.

Premarket Picks

Algorhythm Holdings, Inc. (RIME) saw a pre-market price of $0.12, surging by 32.61%. The surge was driven by the company’s announcement of the successful closing of a $9.5 million public offering.

Gaxos.ai Inc. (GXAI) experienced a 50.77% increase, bringing its pre-market price to $3.92. This surge followed the company’s release of a visual editor for Godot Engine, designed to enhance their artificial intelligence solution for game developers and publishers under the name Gaxos Labs.

Innate Pharma S.A. (IPHA) rose by 25.17%, with a pre-market price of $1.84. The increase followed the announcement of promising new data from the TELLOMAK Phase 2 clinical study, which highlighted improvements in the quality of life for patients with cutaneous T-cell lymphoma (CTCL) treated with lacutamab.

MEDIROM Healthcare Technologies Inc. (MRM) saw a pre-market price of $4.27, surging by 49.30%. The company’s boost came after the announcement that its subsidiary, MEDIROM MOTHER Labs Inc., had received orders for over 25,000 MOTHER Bracelet units, including orders from Japanese companies such as NFES Technologies Inc.

Below is a complete list of hot stocks in pre-market today:

Top Upgrades:

1. PayPal Holdings, Inc. (PYPL)

Analyst Firm: Bank of America
Upgrade: Neutral to Buy
Price Target: $103
Yesterday's Close: $89.88

Bank of America analyst Jason Kupferberg raised PayPal’s rating from Neutral to Buy, setting a new price target of $103, up from $86.

PayPal's stock price target estimates show a high of $125.00, a median of $91.00, and a low of $70.00, with an average target of $91.86. With over 25 years of experience in transforming global commerce, PayPal continues to empower consumers and businesses in nearly 200 markets, providing simple, secure, and personalized services for money transfers, shopping, and selling.

2. The RealReal, Inc. (REAL)

Analyst Firm: Wells Fargo
Upgrade: Equal Weight to Overweight
Price Target: $15
Yesterday's Close: $6.44

Wells Fargo boosted RealReal’s rating from Equal Weight to Overweight, increasing the price target to $15, up from $4.

The RealReal, the world’s largest online marketplace for authenticated, resale luxury goods, has a stock price target range with a high of $6.75, a median of $4.00, and a low of $3.25. The average target is $4.80. With a member base of 37 million, The RealReal continues to lead in the luxury resale market.

3. Newell Brands Inc. (NWL)

Analyst Firm: Truist
Upgrade: Hold to Buy
Price Target: $17
Yesterday's Close: $10.31

Truist upgraded Newell Brands from Hold to Buy, with a new price target of $17, up from $10.

Newell Brands (NWL) has a stock price target with a high of $15.00, a median of $9.50, and a low of $8.00. The average target stands at $9.73. Known for its portfolio of popular consumer brands such as Rubbermaid, Sharpie, Graco, Coleman, Yankee Candle, and Paper Mate, Newell Brands remains a leader in the global consumer goods sector.

Happy investing,

Maeve Grace
Editor In Chief
Premium Stock Alerts

Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.

Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.